Company Filing History:
2 out of 3,539 
1 out of 42 
1 out of 1 Years Active: 2023-2025
Title: Rommy M Von Bernhardi: Innovator in c-Abl Tyrosine Kinase Inhibitors
Introduction
Rommy M Von Bernhardi is a notable inventor based in Santiago, Chile. She has made significant contributions to the field of biomedical research, particularly in the development of compounds that inhibit c-Abl tyrosine kinase. With a total of 2 patents, her work has the potential to impact the treatment of various diseases.
Latest Patents
Her latest patents focus on c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same. These compounds are designed to inhibit c-Abl tyrosine kinase, which plays a crucial role in various cellular pathways. The novel c-Abl inhibitors can bind to c-Abl at an allosteric site, effectively inhibiting its activity. Importantly, these compounds are capable of crossing the blood-brain barrier, making them useful for targeting c-Abl activity in the brain. This innovation holds promise for treating diseases such as cancers, motor neuron diseases, and neurodegenerative disorders.
Career Highlights
Rommy has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Pontificia Universidad Catolica De Chile. Her experience in these institutions has contributed to her expertise in the field of biomedical research.
Collaborations
Throughout her career, Rommy has collaborated with notable colleagues, including Juan Jose Marugan and Marc Ferrer. These partnerships have likely enhanced her research and development efforts in the area of c-Abl inhibitors.
Conclusion
Rommy M Von Bernhardi is a pioneering inventor whose work on c-Abl tyrosine kinase inhibitors is paving the way for new therapeutic approaches to treat serious diseases. Her contributions to biomedical research are commendable and hold great promise for future advancements in medicine.